Selenious Acid Injection is a trace element indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or ...

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma ...

The following are 13 tips for safe and appropriate use of single-dose and multiple-dose vials for injected medication from The Joint Commission’s recent sentinel alert on the subject: 1. Discard any ...

Purified Cortrophin Gel is now available in a 1mL multiple-dose vial (80 USP units/1mL) Purified Cortrophin ® Gel (repository corticotropin injection USP) is now available in a 1mL multiple-dose vial ...

German drug maker Sandoz on Thursday announced a recall of two sizes of methotrexate injection vials sold under the Sandoz and Parenta brands because of the possible presence of glass flakes. “While ...

The FDA approved a larger 375-milligram vial of nelarabine to address dosing challenges in T-ALL and T-LBL treatment. The new vial size allows for more precise dosing, especially beneficial for ...

July 12, 2012 — Repeated use of single-use medication vials has been linked to the transmission of life-threatening Staphylococcus aureus infection in 10 patients treated for pain in outpatient ...

New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma CAMBRIDGE, Mass., January 28, ...

New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Shorla Oncology ('Shorla'), a ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, ...